SCHEMBL15480683

SCHEMBL15480683

N#Cc1cccc(C(=O)Nc2csc(-c3ccc(Br)cc3)c2C(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
HDAC2 Q92769 1/20 0.43
GRM5 P41594 3/20 0.42
AKR1C2 P52895 2/20 0.41
AKR1C1 Q04828 2/20 0.41
AKR1C4 P17516 1/20 0.41
AKR1C3 P42330 1/20 0.41
RXFP1 Q9HBX9 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.40
TP53 P04637 1/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12756891 0.90 CASP3 (0.48) CASP3SENP8SENP7SENP6HDAC2
SCHEMBL1490703 0.87 KMT2A (0.49) CASP3SENP8SENP7SENP6HDAC2
SCHEMBL12831064 0.87 CASP3 (0.55) CASP3SENP8SENP7SENP6HDAC2
SCHEMBL12756880 0.84 HDAC2 (0.55) CASP3SENP8SENP7SENP6HDAC2
SCHEMBL1490272 0.84 CASP3 (0.67) CASP3SENP8SENP7SENP6HDAC2
SCHEMBL1490367 0.84 MEN1 (0.50) CASP3SENP8SENP7SENP6HDAC2
SCHEMBL12830935 0.84 CASP3 (0.50) CASP3SENP8SENP7SENP6HDAC2
SCHEMBL12756873 0.83 THRB (0.55) CASP3SENP8SENP7SENP6HDAC2
SCHEMBL1490556 0.82 MEN1 (0.54) CASP3SENP8SENP7SENP6HDAC2
SCHEMBL15233173 0.81 CASP3 (0.72) CASP3SENP8SENP7SENP6KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 CASP3 2232/4885SENP8 3756/4885SENP7 3940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.